Vascular endothelial growth factor as a marker of disease activity in neurotuberculosis

Nuzhat Husain, Seema Awasthi, Mohammad Haris, Rakesh K. Gupta, Mazhar Husain

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Vascular endothelial growth factor (VEGF) is a potent angiogenesis mediator. Scant reports are available defining the role of VEGF in active and inactive tubercular meningitis (TBM) with no studies on brain tuberculoma. We quantified VEGF levels by enzyme linked immunoassay (ELISA) in cerebrospinal fluid (CSF) and serum in 20 cases each with active and inactive TBM as well as 22 cases of intraparenchymal tuberculoma. VEGF expression and microvessel angiogenesis quantification was done in 7 cases where tuberculomas were excised. Significantly increased VEGF levels in CSF were found in active TBM cases (106.0 ± 50.0 pg/ml) compared to inactive TBM cases (14.7 ± 10.0 pg/ml) (p < 0.001). Mean serum VEGF levels in active TBM, inactive TBM and tuberculoma were 694.93 ± 820.66 pg/ml, 499.61 ± 238.33 pg/ml and 541.0 ± 389.0 pg/ml, respectively. Immunohistochemical staining of excised tuberculoma demonstrated high expression of VEGF in granulomatous areas with intense positivity in inflammatory mononuclear cells, Langhan's giant cells as well as reactive astrocytes and fibrocytes. A strong positive correlation was observed between microvessel density and VEGF expression. Serial decrease in serum VEGF levels was observed with increasing duration of therapy in tuberculoma. We conclude that increased CSF and serum VEGF levels are a measure of activity of the disease in neurotuberculosis and its gradual decrease over a period of time is probably an indicator of therapeutic response.

Original languageEnglish
Pages (from-to)114-119
Number of pages6
JournalJournal of Infection
Volume56
Issue number2
DOIs
Publication statusPublished - Feb 2008
Externally publishedYes

Fingerprint

Vascular Endothelial Growth Factor A
Tuberculoma
Meningeal Tuberculosis
Cerebrospinal Fluid
Microvessels
Serum
Langhans Giant Cells
Immunoenzyme Techniques
Astrocytes
Staining and Labeling
Brain
Therapeutics

Keywords

  • Angiogenesis
  • CNS
  • Meningitis
  • Tuberculoma
  • VEGF

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Cite this

Vascular endothelial growth factor as a marker of disease activity in neurotuberculosis. / Husain, Nuzhat; Awasthi, Seema; Haris, Mohammad; Gupta, Rakesh K.; Husain, Mazhar.

In: Journal of Infection, Vol. 56, No. 2, 02.2008, p. 114-119.

Research output: Contribution to journalArticle

Husain, Nuzhat ; Awasthi, Seema ; Haris, Mohammad ; Gupta, Rakesh K. ; Husain, Mazhar. / Vascular endothelial growth factor as a marker of disease activity in neurotuberculosis. In: Journal of Infection. 2008 ; Vol. 56, No. 2. pp. 114-119.
@article{a9bb20e5e884459baa1fce683f6ab5c9,
title = "Vascular endothelial growth factor as a marker of disease activity in neurotuberculosis",
abstract = "Vascular endothelial growth factor (VEGF) is a potent angiogenesis mediator. Scant reports are available defining the role of VEGF in active and inactive tubercular meningitis (TBM) with no studies on brain tuberculoma. We quantified VEGF levels by enzyme linked immunoassay (ELISA) in cerebrospinal fluid (CSF) and serum in 20 cases each with active and inactive TBM as well as 22 cases of intraparenchymal tuberculoma. VEGF expression and microvessel angiogenesis quantification was done in 7 cases where tuberculomas were excised. Significantly increased VEGF levels in CSF were found in active TBM cases (106.0 ± 50.0 pg/ml) compared to inactive TBM cases (14.7 ± 10.0 pg/ml) (p < 0.001). Mean serum VEGF levels in active TBM, inactive TBM and tuberculoma were 694.93 ± 820.66 pg/ml, 499.61 ± 238.33 pg/ml and 541.0 ± 389.0 pg/ml, respectively. Immunohistochemical staining of excised tuberculoma demonstrated high expression of VEGF in granulomatous areas with intense positivity in inflammatory mononuclear cells, Langhan's giant cells as well as reactive astrocytes and fibrocytes. A strong positive correlation was observed between microvessel density and VEGF expression. Serial decrease in serum VEGF levels was observed with increasing duration of therapy in tuberculoma. We conclude that increased CSF and serum VEGF levels are a measure of activity of the disease in neurotuberculosis and its gradual decrease over a period of time is probably an indicator of therapeutic response.",
keywords = "Angiogenesis, CNS, Meningitis, Tuberculoma, VEGF",
author = "Nuzhat Husain and Seema Awasthi and Mohammad Haris and Gupta, {Rakesh K.} and Mazhar Husain",
year = "2008",
month = "2",
doi = "10.1016/j.jinf.2007.11.004",
language = "English",
volume = "56",
pages = "114--119",
journal = "Journal of Infection",
issn = "0163-4453",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Vascular endothelial growth factor as a marker of disease activity in neurotuberculosis

AU - Husain, Nuzhat

AU - Awasthi, Seema

AU - Haris, Mohammad

AU - Gupta, Rakesh K.

AU - Husain, Mazhar

PY - 2008/2

Y1 - 2008/2

N2 - Vascular endothelial growth factor (VEGF) is a potent angiogenesis mediator. Scant reports are available defining the role of VEGF in active and inactive tubercular meningitis (TBM) with no studies on brain tuberculoma. We quantified VEGF levels by enzyme linked immunoassay (ELISA) in cerebrospinal fluid (CSF) and serum in 20 cases each with active and inactive TBM as well as 22 cases of intraparenchymal tuberculoma. VEGF expression and microvessel angiogenesis quantification was done in 7 cases where tuberculomas were excised. Significantly increased VEGF levels in CSF were found in active TBM cases (106.0 ± 50.0 pg/ml) compared to inactive TBM cases (14.7 ± 10.0 pg/ml) (p < 0.001). Mean serum VEGF levels in active TBM, inactive TBM and tuberculoma were 694.93 ± 820.66 pg/ml, 499.61 ± 238.33 pg/ml and 541.0 ± 389.0 pg/ml, respectively. Immunohistochemical staining of excised tuberculoma demonstrated high expression of VEGF in granulomatous areas with intense positivity in inflammatory mononuclear cells, Langhan's giant cells as well as reactive astrocytes and fibrocytes. A strong positive correlation was observed between microvessel density and VEGF expression. Serial decrease in serum VEGF levels was observed with increasing duration of therapy in tuberculoma. We conclude that increased CSF and serum VEGF levels are a measure of activity of the disease in neurotuberculosis and its gradual decrease over a period of time is probably an indicator of therapeutic response.

AB - Vascular endothelial growth factor (VEGF) is a potent angiogenesis mediator. Scant reports are available defining the role of VEGF in active and inactive tubercular meningitis (TBM) with no studies on brain tuberculoma. We quantified VEGF levels by enzyme linked immunoassay (ELISA) in cerebrospinal fluid (CSF) and serum in 20 cases each with active and inactive TBM as well as 22 cases of intraparenchymal tuberculoma. VEGF expression and microvessel angiogenesis quantification was done in 7 cases where tuberculomas were excised. Significantly increased VEGF levels in CSF were found in active TBM cases (106.0 ± 50.0 pg/ml) compared to inactive TBM cases (14.7 ± 10.0 pg/ml) (p < 0.001). Mean serum VEGF levels in active TBM, inactive TBM and tuberculoma were 694.93 ± 820.66 pg/ml, 499.61 ± 238.33 pg/ml and 541.0 ± 389.0 pg/ml, respectively. Immunohistochemical staining of excised tuberculoma demonstrated high expression of VEGF in granulomatous areas with intense positivity in inflammatory mononuclear cells, Langhan's giant cells as well as reactive astrocytes and fibrocytes. A strong positive correlation was observed between microvessel density and VEGF expression. Serial decrease in serum VEGF levels was observed with increasing duration of therapy in tuberculoma. We conclude that increased CSF and serum VEGF levels are a measure of activity of the disease in neurotuberculosis and its gradual decrease over a period of time is probably an indicator of therapeutic response.

KW - Angiogenesis

KW - CNS

KW - Meningitis

KW - Tuberculoma

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=38749106123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38749106123&partnerID=8YFLogxK

U2 - 10.1016/j.jinf.2007.11.004

DO - 10.1016/j.jinf.2007.11.004

M3 - Article

VL - 56

SP - 114

EP - 119

JO - Journal of Infection

JF - Journal of Infection

SN - 0163-4453

IS - 2

ER -